A nurse is assessing a 68-year-old client who has been diagnosed with multiple myeloma. Which assessment finding would be most characteristic of this condition?

Bone pain, especially in the back and ribs, is the most characteristic finding in multiple myeloma due to osteolytic lesions. Other options are more typical of lymphoma (enlarged lymph nodes), thrombocytopenia (petechiae), or respiratory conditions (shortness of breath).

Core Nursing Explanation Key Concept Analysis: This question tests the identification of the hallmark clinical manifestation of Multiple Myeloma (MM). MM is a cancer of plasma cells (a type of white blood cell) in the bone marrow. The malignant plasma cells produce abnormal antibodies (M proteins) and release substances that stimulate osteoclasts, leading to bone destruction (osteolytic lesions). This pathophysiology directly causes the most characteristic symptom.

Answer Rationale: Key Point! The correct answer is ① Bone pain, particularly in the back and ribs. This pain results from the lytic bone lesions and pathologic fractures caused by the disease process. The vertebrae (back) and ribs are common sites because they contain red marrow and are weight-bearing or susceptible to stress. This pain is often persistent, severe, and worsens with movement.

Distractor Analysis:
② Enlarged lymph nodes in the neck and axilla: This is a classic sign of Watch out for confusion! Lymphomas (e.g., Hodgkin's, Non-Hodgkin's), not multiple myeloma. While both are hematologic cancers, myeloma originates in plasma cells within the bone marrow, not primarily in lymph nodes.
③ Petechiae and bruising on the extremities: These are signs of thrombocytopenia (low platelet count). Although myeloma can cause bone marrow suppression leading to pancytopenia (including low platelets), it is not the most characteristic finding. Petechiae are more immediately associated with conditions like leukemia or immune thrombocytopenic purpura (ITP).
④ Shortness of breath and chest tightness: These are typical of primary cardiac or pulmonary conditions (e.g., heart failure, asthma, COPD). In the context of hematologic disorders, severe anemia from myeloma could cause dyspnea on exertion, but it is not the pathognomonic (defining) symptom. Chest tightness is not a hallmark of myeloma.

Related Concepts: The classic triad for multiple myeloma is sometimes remembered as "CRAB": Calcium elevation (hypercalcemia), Renal failure, Anemia, and Bone lesions. Bone pain is the clinical manifestation of the "B." Diagnosis often involves serum protein electrophoresis (SPEP) showing an M-spike, bone marrow biopsy with >10% plasma cells, and skeletal survey showing "punched-out" lytic lesions.

Concept Summary

Concept	Key Points
Disease	Multiple Myeloma (Plasma Cell Cancer)
Pathophysiology	Malignant plasma cells in bone marrow produce abnormal antibodies (M proteins) and cytokines (e.g., RANKL) that activate osteoclasts, causing bone destruction.
Hallmark Symptom	Bone pain (back, ribs, skull) from osteolytic lesions and pathologic fractures.
Diagnostic Clues	CRAB criteria, elevated serum calcium, Bence Jones protein in urine, M-spike on SPEP.
Common Complications	Hypercalcemia, renal failure (from light chain deposition), anemia, infections (impaired normal antibody production).

Side-by-Side Comparison!

Feature	Multiple Myeloma	Lymphoma (e.g., Non-Hodgkin's)
Cell of Origin	Plasma cell (in bone marrow)	Lymphocyte (in lymph nodes)
Primary Site	Bone marrow	Lymph nodes, lymphatic tissue
Characteristic Sign	Bone pain (lytic lesions)	Painless lymphadenopathy (swollen nodes)
Lab Finding	M-protein (monoclonal gammopathy)	Often no specific serum protein spike

Anatomy, Physiology & Pharmacology Points

• Bone Remodeling: Myeloma disrupts the balance between osteoclasts (bone-resorbing) and osteoblasts (bone-forming). Cytokines like RANKL tip the scale toward excessive bone breakdown.
• Renal Involvement: The light chains of the abnormal antibodies (Bence Jones proteins) can clog renal tubules, leading to "myeloma kidney" and renal failure.
• Drug Therapy: Common treatments include proteasome inhibitors (e.g., bortezomib), immunomodulatory drugs (e.g., lenalidomide), and monoclonal antibodies. Bisphosphonates (e.g., zoledronic acid) are used to inhibit osteoclast activity and reduce bone pain/fracture risk.

Memory Tips

• CRAB for the major complications: Calcium (high), Renal failure, Anemia, Bone lesions.
• M-Myeloma = M-protein = Marrow & Bones. Think of the "M" connecting the disease to its origin (Marrow) and main problem (bone pain).
• Bone pain in the back/ribs in an older adult + fatigue (anemia) should raise suspicion for myeloma.

High-Frequency NCLEX Topics NCLEX often tests the Key Point! characteristic assessment finding of a disease. For multiple myeloma, bone pain is the #1 answer. Be prepared for questions on priority nursing interventions: managing pain, preventing injury/fractures, monitoring for signs of hypercalcemia (confusion, polyuria, constipation) and renal failure, and teaching about infection prevention due to immunosuppression.

Watch Out for Question Variations!

• Symptom → Priority Nursing Diagnosis: "The nurse identifies which nursing diagnosis as the priority for a client with multiple myeloma reporting severe back pain?" Answer: Acute Pain or Risk for Injury.
• Symptom → Underlying Cause: "A client with multiple myeloma has severe bone pain. The nurse understands this is primarily caused by which pathophysiological process?" Answer: Osteoclastic bone destruction (lytic lesions).
• Lab Value Interpretation: "Which lab result would the nurse expect to find in a client with multiple myeloma?" Answer: Elevated serum calcium or Presence of M-protein on SPEP.

Nursing Clinical Practice Guide Clinical Scenario: You are caring for Mr. Johnson, a 68-year-old male admitted with a diagnosis of multiple myeloma. He reports a 3-month history of progressively worsening, deep, aching pain in his mid-back and ribs that is worse with movement and at night. He appears fatigued and pale.

Nursing Intervention Strategy:

1. Assessment: Perform a comprehensive pain assessment using PQRST (Provoking/Palliating, Quality, Region/Radiation, Severity, Timing). Key Point! Gently palpate bony prominences; avoid vigorous manipulation due to fracture risk. Monitor vital signs, neurological status (for hypercalcemia), and intake/output (for renal function).
2. Nursing Diagnosis & Planning: Priorities include Acute Pain related to bone destruction, Risk for Injury related to pathologic fractures and hypercalcemia, and Risk for Infection related to immunosuppression. The plan focuses on pain control, safety, and monitoring complications.
3. Implementation:
   • Pain Management: Administer analgesics (often opioids) as scheduled and for breakthrough pain. Coordinate with physical therapy for gentle, non-weight-bearing exercises. Apply heat pads for muscle relaxation (with caution on sensitive skin).
   • Safety & Mobility: Implement fall precautions. Use a lift sheet for repositioning; log-roll the patient if spinal involvement is suspected. Ensure the environment is clutter-free.
   • Monitoring & Care: Administer bisphosphonate infusions as ordered (monitor for acute-phase reactions like fever and for renal function). Encourage fluid intake (2-3 L/day if not contraindicated) to help excrete calcium and light chains, protecting renal function. Monitor for signs of infection (fever, cough) as the patient is immunocompromised.
4. Patient Education & Evaluation: Teach the patient to report new or worsening pain, signs of fracture (sudden, sharp pain), symptoms of hypercalcemia (excessive thirst, confusion, nausea), and infection. Evaluate pain control using a numeric scale and assess for any new neurological deficits or changes in renal lab values.

Patient Safety and Precautions:

• Contraindications/Cautions: Avoid NSAIDs for pain if renal function is impaired. Bisphosphonates are contraindicated in severe renal impairment. Handle the patient gently to prevent pathologic fractures.
• Key Monitoring: Frequent lab monitoring: Serum calcium (>10.2 mg/dL is hypercalcemia), creatinine (for renal function), complete blood count (CBC) for anemia and neutropenia.

Nursing Procedure & Medication Flow Administering Intravenous Bisphosphonate (e.g., Zoledronic Acid):

1. Pre-administration: Verify order. Assess baseline renal function (serum creatinine) and electrolyte levels (calcium). Ensure the patient is well-hydrated; may need IV fluids before infusion.
2. Preparation: Reconstitute/dilute per protocol. Administer via IV infusion over no less than 15 minutes (usually over 30-60 min). Rapid infusion increases risk of renal toxicity.
3. During & After: Monitor for infusion reactions (fever, flu-like symptoms, bone pain – "acute phase reaction") which are common in the first 3 days. Monitor vital signs and I&O. Encourage oral hydration after infusion.
4. Patient Teaching: Inform the patient that flu-like symptoms are possible but manageable. Emphasize the importance of good oral hygiene and regular dental check-ups due to a rare but serious side effect: osteonecrosis of the jaw (ONJ).

A Word from Your Senior Nurse "Multiple myeloma teaches us the importance of connecting pathophysiology to the patient's lived experience. That bone pain isn't just a symptom on a chart; it's what keeps your patient up at night and afraid to move. Your vigilant assessment and gentle, knowledgeable care can make a world of difference. When you see an older adult with unexplained back pain and fatigue, let the 'CRAB' criteria run through your mind. In clinicals and on the NCLEX, always ask yourself: 'What is the hallmark of this condition?' and 'What is the biggest threat to my patient right now?' For myeloma, it's often the pain and the risk of fracture or renal failure. Think like a nurse – protect, monitor, educate."